ACET
Adicet Bio, Inc.Company with tickers: ACET
CIK
1720580
CUSIP
007002207
Shares Outstanding
9,348,236
13F Activity (30d)
41 filings
40 filers
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-04-09 | OrbiMed Genesis Master Fund, L.P. | Shareholder | 78,499 | 2026-04-09 | Themis Trading LLC |
| 2026-04-08 | OrbiMed Israel Partners II, L.P. | Shareholder | 40,416 | 2026-04-08 | Themis Trading LLC |
| 2026-04-07 | OrbiMed Israel Partners Limited Partnership | Shareholder | 64,242 | 2026-04-07 | Themis Trading LLC |
| 2024-06-05 | Kauffman Michael | Director | 5,900 | 2024-06-05 | Morgan Stanley Smith Barney LLC Executive Services |
| 2023-09-29 | CHEN SCHOR | Officer, Director | 5,500 | 2023-09-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–5 of 5 filings